On September 27, 2024, in USA v. California Stem Cell Treatment Center, Inc., the US Court of Appeals for the Ninth Circuit issued a decision agreeing with the US Food and Drug Administration (FDA) ...

A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients ...

MIAMI, June 5, 2025 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity company, announced today that it has published, in the Peer-Reviewed Journal of Stem Cell Research & Therapeutics, data ...

The Federal Circuit issued a precedential opinion on March 4, 2025, that serves as valuable guidance for product-by-process claims, particularly in the context of inherency in claim construction. In ...

Add Yahoo as a preferred source to see more of our stories on Google. Under Health and Human Services Secretary Robert F. Kennedy Jr., will the Food and Drug Administration still rein in bogus claims ...

CARLSBAD, Calif., Sept. 10, 2025 /PRNewswire/ -- The science of stem cells has ushered in groundbreaking health options in the last decade, yet those options have lacked the affordability and ease to ...

Stem cells made a public splash with large research breakthroughs in the 90s and early 2000s. However, since then, stem cells have largely been adopted by the alternative medicine and wellness world ...

Stem cell therapy uses cells capable of developing into other cell types to attempt to repair tissue. The honest 2026 reality: the only FDA-approved stem cell products in the US are cord-blood-derived ...

The global stem cell therapy market is entering an era of unprecedented growth and innovation. Valued at $5.13 billion in 2024, the U.S. stem cell market alone is projected to reach $15.79 billion by ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. “Stem cells are basically specialized cells that are there to repair, regenerate and renew ...

A single intravenous infusion of stem cells harvested from the bone marrow of young adult donors improved walking endurance in frail older adults aged 70 to 85, according to a Phase 2b clinical trial ...

Newswise — SEATTLE — April, 27, 2026 — A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A phase ...